|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||
| 化学式 | C16H15N7O2 |
||||||
| 分子量 | 337.34 | CAS No. | 139180-30-6 | ||||
| Solubility (25°C)* | 体外 | DMSO | 67 mg/mL (198.61 mM) | ||||
| Water | Insoluble | ||||||
| Ethanol | Insoluble | ||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||
| 製品説明 | ZM-241385は、アデノシンA2A受容体に選択的な高親和性拮抗薬リガンドです。 |
|---|---|
| in vitro | ZM 241385 has high affinity for A2a receptors. In rat phaeochromocytoma cell membranes, ZM 241385 displaces binding of tritiated 5'-N-ethylcarboxamidoadenosine (NECA) with a pIC50 of 9.52. ZM241385 delays the appearance of anoxic depolarization (AD), a phenomenon strictly related to cell damage and death, protect from the synaptic activity depression brought about by a severe (7 min) OGD period, and protect CA1 neuron and astrocyte from injury. |
| in vivo | ZM-241385 significantly blunts the hypotensive effects of CCPA and NECA without altering the bradycardia induced by these agonists. It blocks the infarct size-reducing effects(cardioprotective effects) of this two distinct adenosine receptor agonists. |
| 細胞アッセイ | 細胞株 | PC12 cells |
|---|---|---|
| 濃度 | 1 μM | |
| 反応時間 | 24 h | |
| 実験の流れ | Nitric oxide (NO) production is assessed by measuring the amount of nitrite, a stable metabolic product of NO that provides an indirect measurement of NO, by using the Griess diazotization reaction. Briefly, 24 h after incubation with 1.0 µM CG21680 or 1.0 µM ZM241385 or exposure to SMF, samples of medium (150 µl) are collected from cells and mixed with 130 µl dH2O and with 20 µl Griess reagent using instruction supplied by the manufacturer. After a 30 min incubation period at room temperature, the samples are evaluated spectrophotometrically at 548 nm and OD values-in comparison with a standard curve is determined in culture medium by using serial dilutions of sodium nitrite-represented total stable metabolites of NO. |
|
| 動物実験 | 動物モデル | Adult Sprague-Dawley rats |
| 投薬量 | 1.5 mg/kg | |
| 投与方法 | i.v. |
|

Data from [Data independently produced by , , Biochem Pharmacol, 2018, doi: 10.1016/j.bcp.2018.01.033]
| Adenosine signalling drives antidepressant actions of ketamine and ECT [ Nature, 2025, 10.1038/s41586-025-09755-9] | PubMed: 41193806 |
| Clustering Mycobacterium tuberculosis-specific CD154+CD4+ T cells for distinguishing tuberculosis disease from infection based on single-cell RNA-seq analysis [ J Infect, 2025, 90(4):106449] | PubMed: 40010539 |
| Adenosine Kinase Inhibition Prevents Severe Acute Pancreatitis via Suppressing Inflammation and Acinar Cell Necroptosis [ Front Cell Dev Biol, 2022, 10:827714] | PubMed: 35281076 |
| Exogenous adenosine activates A2A adenosine receptor to inhibit RANKL-induced osteoclastogenesis via AP-1 pathway to facilitate bone repair [ Mol Biol Rep, 2021, 10.1007/s11033-021-07017-1] | PubMed: 34846650 |
| Ticagrelor Inhibits the NLRP3 Inflammasome to Protect Against Inflammatory Disease Independent of the P2Y 12 Signaling Pathway [ Cell Mol Immunol, 2020, 10] | PubMed: 32523112 |
| Blockade of Adenosine A 2A Receptor Protects Photoreceptors after Retinal Detachment by Inhibiting Inflammation and Oxidative Stress [ Oxid Med Cell Longev, 2020, 2020:7649080] | PubMed: 32714489 |
| The Adenosine A2A Receptor Agonist Accelerates Bone Healing and Adjusts Treg/Th17 Cell Balance Through Interleukin 6 [ Biomed Res Int, 2020, 2020:2603873] | PubMed: 32382539 |
| The cAMP-Adenosine Feedback Loop Maintains the Suppressive Function of Regulatory T Cells [ J Immunol, 2019, 203(6):1436-1446] | PubMed: 31420466 |
| A novel combination of astilbin and low-dose methotrexate respectively targeting A2AAR and its ligand adenosine for the treatment of collagen-induced arthritis [Ma Y Biochem Pharmacol, 2018, 153:269-281] | PubMed: 29410374 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。